Decatur Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-7,860
Closed -$1.22M 60
2023
Q1
$1.22M Sell
7,860
-1,480
-16% -$239K 0.92% 42
2022
Q4
$1.65M Hold
9,340
1.19% 31
2022
Q3
$1.53M Buy
9,340
+7
+0.1% +$1.19K 1.15% 29
2022
Q2
$1.66M Buy
9,333
+25
+0.3% +$4.45K 1.23% 30
2022
Q1
$1.65M Buy
9,308
+928
+11% +$158K 0.96% 34
2021
Q4
$1.43M Sell
8,380
-100
-1% -$16.4K 0.85% 45
2021
Q3
$1.37M Sell
8,480
-10,010
-54% -$1.71M 0.9% 43
2021
Q2
$3.05M Hold
18,490
0.95% 38
2021
Q1
$3.04M Sell
18,490
-16,653
-47% -$2.69M 1.05% 33
2020
Q4
$5.53M Buy
+35,143
New +$5.19M 1.01% 42

Other funds holding JNJ

Decatur Capital Management's JNJ Position: Q2 2023 in Review

Decatur Capital Management sold out of Johnson & Johnson (JNJ) in Q2 2023, closing a stake of 7,860 shares — an estimated $1.22M sold.

Decatur Capital Management first reported a position in JNJ in Q4 2020 and held it in 10 quarters. The position peaked at $5.53M in Q4 2020. 3,751 funds tracked by Wall St. Rank hold JNJ as of Q2 2023.

  • Decatur Capital Management reported no remaining Johnson & Johnson position as of Q2 2023 after selling out during the quarter.
  • Decatur Capital Management sold 7,860 Johnson & Johnson shares in Q2 2023, an estimated $1.22M.
  • Decatur Capital Management first reported a position in Johnson & Johnson in Q4 2020 and held it in 10 quarters.
  • Decatur Capital Management's Johnson & Johnson position peaked at $5.53M in Q4 2020.
  • 3,751 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2023.

Based on Decatur Capital Management's 13F filing for Q2 2023, filed 9 Aug 2023.